EQ
Equillium, Inc.
Key Financials
Operating Income
$-23634000
↓ 185.8%
EPS (Diluted)
$-0.39
↓ 69.6%
Revenue
$41.1M
0.0%
Total Liabilities
$3.3M
↓ 49.7%
Total Assets
$31.9M
↑ 24.5%
Cash & Equivalents
$30.3M
↑ 67.4%
Operating Cash Flow
$-22746000.00
↓ 19.6%
Long-term Debt
$9.1M
↓ 10.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 144 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 144 | 6/4/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
| 4 | 5/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | EQ |
| Company Name | Equillium, Inc. |
| CIK | 1746466 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (858) 412-5302 |